JP2011092217A - Chemical vaporizer - Google Patents

Chemical vaporizer Download PDF

Info

Publication number
JP2011092217A
JP2011092217A JP2011031529A JP2011031529A JP2011092217A JP 2011092217 A JP2011092217 A JP 2011092217A JP 2011031529 A JP2011031529 A JP 2011031529A JP 2011031529 A JP2011031529 A JP 2011031529A JP 2011092217 A JP2011092217 A JP 2011092217A
Authority
JP
Japan
Prior art keywords
fuel cell
main body
drug
storage chamber
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011031529A
Other languages
Japanese (ja)
Other versions
JP4901999B2 (en
Inventor
Satoshi Yamazaki
聡 山崎
Kazunori Yamamoto
和則 山本
Shinya Kawamura
真也 河村
Koji Takei
康治 武井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fumakilla Ltd
Original Assignee
Fumakilla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fumakilla Ltd filed Critical Fumakilla Ltd
Priority to JP2011031529A priority Critical patent/JP4901999B2/en
Publication of JP2011092217A publication Critical patent/JP2011092217A/en
Application granted granted Critical
Publication of JP4901999B2 publication Critical patent/JP4901999B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/30Hydrogen technology
    • Y02E60/50Fuel cells

Landscapes

  • Catching Or Destruction (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a chemical vaporizer which can use a fuel cell as an electric power source to vaporize a chemical agent in the atmosphere, can be smoothly activated and use a fuel cell even at a place having a low ambient temperature without causing a trouble, and does not affect the chemical agent, when the fuel cell is activated. <P>SOLUTION: The chemical vaporizer is configured to include a fuel cell attaching portion 90 and chemical agent vaporizing means attaching portion 91 on a device body 1 separately on a flat direction, attach the fuel cell 2 on the fuel cell attaching portion 90 so as to expose it on the top of the device body 1, and dispose a blower 19 using the fuel cell 2 as an electric source, and a chemical agent holder 4 blasted by the blower 19 on the chemical agent vaporizing means attaching portion 91, and when the fuel cell 2 is heated by outer heating means at a place having a low ambient temperature, the fuel cell 2 can be heated and smoothly activated, and the heat does not transmit to the chemical agent holder 4 to prevent the adverse affection of the chemical agent. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

本発明は、芳香剤、消臭剤、殺菌剤、殺ダニ剤、害虫あるいは害獣忌避剤、殺虫剤または害虫の成長制御剤、吸血行動阻止剤などの薬剤を、大気に放散させる薬剤放散装置に関する。   The present invention relates to a drug diffusion device that releases a chemical such as a fragrance, a deodorant, a bactericidal agent, an acaricide, a pest or pest repellent, an insecticide or a pest growth control agent, and a blood sucking action inhibitor to the atmosphere. About.

従来より薬剤放散装置の一種として、加熱して薬剤を蒸散させる装置が知られている。例えば、マットタイプの電気蚊取器、薬液ボトルタイプの電気蚊取器と呼ばれるものが知られている。
マットタイプの電気蚊取器は、ピレスロイド系殺虫剤を含浸させたパルプ製マットを表面温度が150〜185℃の板状発熱体上に載置して加熱し、8〜12時間にわたり殺虫成分だけを蒸散させる加熱式薬剤蒸散装置である。
薬液ボトルタイプの電気蚊取器は、ピレスロイド系殺虫剤を溶剤で溶解した薬液を薬液ボトルに収容し、その薬液ボトル中に浸漬した吸液芯の上部を温度が120〜140℃のリング状発熱体内で間接加熱し、30〜90日間にわたり殺虫成分を蒸散させる長期間継続して使用できる加熱式薬剤蒸散装置である。
2. Description of the Related Art Conventionally, a device that heats and vaporizes a drug is known as a kind of drug diffusion device. For example, there are known mat-type electric mosquito catchers and chemical bottle-type electric mosquito catchers.
A mat-type electric mosquito trap is placed on a plate-shaped heating element with a surface temperature of 150 to 185 ° C. and heated with a pulp mat impregnated with a pyrethroid insecticide, and only insecticidal components are applied for 8 to 12 hours. It is a heating type chemical transpiration device that transpirations.
The chemical bottle type electric mosquito trap contains a chemical solution in which a pyrethroid insecticide is dissolved in a solvent, and the upper part of the liquid absorbent core immersed in the chemical solution bottle has a ring-shaped heating element with a temperature of 120 to 140 ° C. It is a heating type chemical transpiration apparatus which can be used continuously for a long period of time by indirect heating and evaporating the insecticidal component for 30 to 90 days.

前述した各電気蚊取器と呼ばれる加熱式薬剤蒸散装置は、交流電源(商用電源)を電源として発熱体を発熱させるのが一般的であるが、この交流電源の代わりに電池を電源として発熱体を発熱させるマットタイプの加熱式薬剤蒸散装置が特許文献1に開示され、薬液ボトルタイプの加熱式薬剤蒸散装置が特許文献2に開示されている。   The above-mentioned heating type chemical transpiration devices called electric mosquito traps generally use an AC power source (commercial power) as a power source to generate heat, but instead of this AC power source, a battery as a power source generates heat. Patent Document 1 discloses a mat type heating type chemical evaporation apparatus that generates heat, and Patent Document 2 discloses a chemical bottle type heating type chemical evaporation apparatus.

また、薬剤放散装置の一種として、超音波により液状の薬剤(つまり、薬液)を霧化し噴霧する超音波式薬剤噴霧装置が特許文献3に開示されている。   Further, Patent Document 3 discloses an ultrasonic drug spraying device that atomizes and sprays a liquid drug (that is, a drug solution) by ultrasonic waves as a kind of drug diffusion device.

また、薬剤放散装置の一種として、特許文献4に開示された送風式薬剤拡散装置が知られている。
この送風式薬剤拡散装置は、装置本体内に、送風機と薬剤容器と電源収納体を設けたもので、その送風機はファンとモータを有し、薬剤容器には揮散性の薬剤が収容され、電源収納体には電池が収納されている。
そして、モータでファンを回転することで薬剤容器に空気を流通して揮散性の薬剤を大気に揮散、拡散する。
Moreover, the ventilation type | formula chemical | medical agent diffusion apparatus disclosed by patent document 4 is known as a kind of chemical | medical agent diffusion apparatus.
This blower-type medicine diffusion device is provided with a blower, a medicine container and a power supply housing in the apparatus main body. The blower has a fan and a motor, and the medicine container contains a volatile medicine and a power supply. A battery is stored in the storage body.
And by rotating a fan with a motor, air is distribute | circulated to a chemical | medical agent container, and a volatile chemical | medical agent is volatilized and spread | diffused to air | atmosphere.

特開平8−23851号公報Japanese Patent Laid-Open No. 8-23851 特開2001−103898公報JP 2001-103898 A 特開平8−215308号公報JP-A-8-215308 特開2002−291392号公報JP 2002-291392 A

前述した各装置は、薬剤を放散するために電源を必要としている。
その電源としては交流電源、電池等が用いられるが、交流電源を使用した装置は、使用場所が電源のある屋内などに制限され、電源のない屋外などでは使えない不便さがある。
また、前述の電池を使用した装置は、使用場所に制限がなく屋外などでも使用できると共に、手軽に何処でも持ち運びできる。
Each of the aforementioned devices requires a power source to dissipate the drug.
As the power source, an AC power source, a battery, and the like are used. However, an apparatus using the AC power source is inconvenient that the place of use is limited to an indoor place where the power source is used, and cannot be used outdoors where there is no power source.
In addition, the above-described apparatus using a battery can be used outdoors without restrictions on the place of use, and can be easily carried anywhere.

しかしながら、前述の装置における電源に用いる電池は、アルカリ電池、マンガン電池、リチウム電池などで、その電池は使用時間に限度があり、使用時間を経過した場合には新しい電池と交換し、旧い電池はゴミとして処分している。
このために、経済的に不利であるし、ゴミ処理問題がある。
また、前記超音波式薬剤噴霧装置は、一般的に噴霧時の消費電力が大きく、特に薬液の超微粒子化や霧化量が多量である場合や長時間継続して噴霧する場合は使用電池の本数を多く必要としたり、電池の交換サイクルが短くなるなどから、交換本数や回数が多くなり、ゴミ量が増える。また経済的でない。
However, the batteries used as the power source in the above-mentioned devices are alkaline batteries, manganese batteries, lithium batteries, etc., and the batteries have a limited use time. When the use time has passed, the batteries are replaced with new ones. It is disposed of as trash.
For this reason, it is economically disadvantageous and has a problem of waste disposal.
In addition, the ultrasonic drug spraying apparatus generally consumes a large amount of power during spraying, especially when the amount of atomized or atomized chemical liquid is large or when spraying continuously for a long time. Since a large number of batteries are required or the battery replacement cycle is shortened, the number and the number of replacements are increased, and the amount of garbage is increased. It is also not economical.

本発明者等は、前述の薬剤放散装置に用いる電源としての電池について鋭意研究した結果、近年、燃料として水素を用い、空気中の酸素と化学反応させて発電する小型の燃料電池が開発されていることに着目し、その小型の燃料電池を電源として用いることで長時間に亘って使用できるし、ゴミ処理問題が生じることがない薬剤放散装置とすることができることを見出した。   As a result of earnest research on the battery as a power source used in the above-described drug diffusion device, the present inventors have recently developed a small fuel cell that uses hydrogen as a fuel and chemically reacts with oxygen in the air to generate power. In view of the fact that the small fuel cell is used as a power source, it has been found that it can be used for a long time, and that it can be a drug diffusion device that does not cause a problem of dust disposal.

しかし、燃料電池は使用する環境温度が低い場合には発電開始、つまり起動し難い問題がある。
このために、燃料電池を電源として用いた薬剤放散装置は環境温度が低い場合での使用に問題がある。
However, the fuel cell has a problem that it is difficult to start power generation, that is, to start when the environmental temperature is low.
For this reason, there is a problem in use of the drug diffusion device using the fuel cell as a power source when the environmental temperature is low.

そこで、本発明者等は、燃料電池を起動時に加熱昇温して起動し易くすることを見出したが、燃料電池を加熱する際に、その熱が薬剤に悪影響を及ぼすことがあった。   Therefore, the present inventors have found that the temperature of the fuel cell is increased by heating to make it easier to start, but when the fuel cell is heated, the heat may adversely affect the drug.

本発明の目的は、燃料電池を電源として用いることで長時間に亘って使用できるし、ゴミ処理問題が生じることがなく、しかも環境温度が低い場所でも薬剤に悪影響を及ぼすことなく容易に起動できるようにした薬剤放散装置とすることである。   The object of the present invention is to use the fuel cell as a power source for a long time, to prevent the problem of waste disposal, and to easily start up without adversely affecting the medicine even in a place where the environmental temperature is low. It is to make it the chemical | medical agent diffusion apparatus which was made to do.

第1の発明は、装置本体1に、燃料電池取付部90と薬剤放散手段取付部91を平面方向に離隔して形成し、
前記燃料電池取付部90に燃料電池2を、装置本体1の上面又は下面又は側面に露出するように取付け、
前記薬剤放散手段取付部91に、前記燃料電池2を電源として薬剤を大気に放散する薬剤放散手段を取付けたことを特徴とする薬剤放散装置である。
1st invention forms in the apparatus main body 1 the fuel cell attachment part 90 and the chemical | drug | medicine diffusion means attachment part 91 spaced apart in the plane direction,
The fuel cell 2 is attached to the fuel cell attachment portion 90 so as to be exposed on the upper surface, the lower surface or the side surface of the apparatus main body 1,
The drug diffusing device is characterized in that a drug diffusing means for diffusing a drug into the atmosphere using the fuel cell 2 as a power source is attached to the drug diffusing means mounting portion 91.

第2の発明は、第1の発明において、前記燃料電池取付部90は、装置本体1の上面に開口した電池本体収納室14と燃料タンク収納室15を有し、その電池本体収納室14に電池本体20を設け、燃料タンク収納室15に燃料タンク21を設けた薬剤放散装置である。   In a second aspect based on the first aspect, the fuel cell mounting portion 90 has a battery main body storage chamber 14 and a fuel tank storage chamber 15 that are open on the upper surface of the apparatus main body 1. This is a drug diffusion device in which a battery body 20 is provided and a fuel tank 21 is provided in a fuel tank storage chamber 15.

第3の発明は、第1の発明において、前記電池本体収納室14、燃料タンク収納室15の上面の開口を閉塞する蓋体92を着脱自在に設けた薬剤放散装置である。   A third invention is the drug diffusion device according to the first invention, wherein a lid 92 for detachably closing the upper surfaces of the battery main body storage chamber 14 and the fuel tank storage chamber 15 is provided.

第4の発明は、第2又は第3の発明において、前記電池本体収納室14と薬剤放散手段取付部91との間に燃料タンク収納室15を設けた薬剤放散装置である。   A fourth invention is the drug diffusion device according to the second or third invention, wherein a fuel tank storage chamber 15 is provided between the battery main body storage chamber 14 and the drug diffusion means mounting portion 91.

第5の発明は、第1又は第2又は第3又は第4の発明において、燃料電池2を電源とする発熱体3と、この発熱体3で加熱されて薬剤を蒸散する薬剤保持体4、又は燃料電池2を電源とする送風機19と、この送風機19による空気が流通することで薬剤を放散する薬剤保持体4、又は燃料電池2を電源とする超音波発振機構7で発振した振動で薬液容器8内の薬液を大気に噴霧することで薬剤放散手段とした薬剤放散装置である。   According to a fifth invention, in the first, second, third, or fourth invention, a heating element 3 that uses the fuel cell 2 as a power source, and a medicine holder 4 that is heated by the heating element 3 to evaporate the medicine, Or the chemical | medical solution by the vibration oscillated with the air blower 19 which uses the fuel cell 2 as a power supply, the chemical | medical agent holding body 4 which disperses a chemical | medical agent by the air by this air blower 19, or the ultrasonic oscillation mechanism 7 which uses the fuel cell 2 as a power supply This is a drug diffusing device which is a drug diffusing means by spraying the chemical solution in the container 8 to the atmosphere.

請求項1に係る発明によれば、燃料電池2を電源として薬剤を放散するので、長時間に亘って使用できるし、燃料電池は再利用できてゴミとならないからゴミ処理問題が生じることがない。
また、環境温度が低い場所で使用する際には、外部加熱手段で燃料電池2を加熱昇温してスムーズに起動でき、問題なく使用できる。
また、装置本体1の燃料電池取付部90と薬剤放散手段取付部91は平面方向に離隔しているので、外部加熱手段で燃料電池2を加熱昇温する際に、この熱が薬剤に伝わり難く、その薬剤に悪影響を及ぼすことがない。
According to the first aspect of the present invention, the chemicals are diffused by using the fuel cell 2 as a power source, so that the fuel cell 2 can be used for a long time, and the fuel cell can be reused and does not become garbage. .
Further, when used in a place where the environmental temperature is low, the fuel cell 2 can be heated and heated smoothly by an external heating means, and can be used without any problem.
Further, since the fuel cell mounting portion 90 and the drug diffusing means mounting portion 91 of the apparatus main body 1 are separated from each other in the plane direction, this heat is not easily transmitted to the drug when the temperature of the fuel cell 2 is increased by the external heating means. Does not adversely affect the drug.

請求項2に係る発明によれば、燃料電池2を外部加熱手段で加熱昇温することが容易である。   According to the invention which concerns on Claim 2, it is easy to heat-heat the fuel cell 2 with an external heating means.

請求項3に係る発明によれば、通常使用時に蓋体92を取り付けて電池本体収納室14、燃料タンク収納室15を閉塞することで、ゴミ等の異物が侵入しないようにできると共に、外観の見栄えを良くすることができる。   According to the third aspect of the present invention, the lid 92 is attached during normal use and the battery main body storage chamber 14 and the fuel tank storage chamber 15 are closed to prevent foreign matters such as dust from entering, The appearance can be improved.

本発明の第1の参考例を示す断面図である。It is sectional drawing which shows the 1st reference example of this invention. 第2本体のみの断面図である。It is sectional drawing of only a 2nd main body. 燃料電池の断面説明図である。It is a section explanatory view of a fuel cell. 第1本体と第2本体をヒンジで連結した状態の断面図である。It is sectional drawing of the state which connected the 1st main body and the 2nd main body with the hinge. 本発明の第2の参考例を示す断面図である。It is sectional drawing which shows the 2nd reference example of this invention. 第1本体と第2本体をヒンジで連結した状態の断面図である。It is sectional drawing of the state which connected the 1st main body and the 2nd main body with the hinge. 本発明の第3の参考例を示す断面図である。It is sectional drawing which shows the 3rd reference example of this invention. 第1本体と第2本体をヒンジで連結した状態の断面図である。It is sectional drawing of the state which connected the 1st main body and the 2nd main body with the hinge. 本発明の実施の形態を示す平面図である。It is a top view which shows embodiment of this invention. 本発明の実施の形態を示す断面図である。It is sectional drawing which shows embodiment of this invention. 蓋体を取付けた状態の断面図である。It is sectional drawing of the state which attached the cover body. 燃料電池を装置本体の下面に露出させるようにした断面図である。It is sectional drawing which exposed the fuel cell to the lower surface of the apparatus main body. 燃料電池を装置本体の側面に露出させるようにした断面図である。It is sectional drawing which exposed the fuel cell to the side surface of the apparatus main body.

本発明の薬剤放散装置の第1の参考例として加熱式の薬剤放散装置について説明する。
図1に示すように、装置本体1に、燃料電池2、発熱体3、薬剤保持体4を設け、その燃料電池2を電源として発熱体3に通電し、その発熱体3が発熱することで薬剤保持体4を加熱し、その薬剤保持体4が保持している薬剤を蒸散し、大気に放散する。
前記装置本体1は第1本体5と第2本体6を備え、第1本体5に発熱体3、薬剤保持体4が設けてあり、第2本体6に燃料電池2が設けてある。
前記第1本体5と第2本体6は接離自在で、薬剤を放散する通常使用時には接合して一体的とし、起動時には分離する。
第1本体5と第2本体6が分離すると第2本体6の上面が開口して燃料電池2が露出する。
As a first reference example of the drug diffusion device of the present invention, a heating type drug diffusion device will be described.
As shown in FIG. 1, the apparatus main body 1 is provided with a fuel cell 2, a heating element 3, and a medicine holder 4, and the heating element 3 is energized with the fuel cell 2 as a power source, and the heating element 3 generates heat. The medicine holding body 4 is heated, and the medicine held by the medicine holding body 4 is evaporated and released to the atmosphere.
The apparatus main body 1 includes a first main body 5 and a second main body 6. The first main body 5 is provided with a heating element 3 and a medicine holder 4, and the second main body 6 is provided with a fuel cell 2.
The first main body 5 and the second main body 6 are detachable, and are joined and integrated during normal use for diffusing drugs, and are separated when activated.
When the first main body 5 and the second main body 6 are separated, the upper surface of the second main body 6 is opened and the fuel cell 2 is exposed.

このようであるから、環境温度が低い時には第1本体5と第2本体6を分離し、外部加熱手段で燃料電池2を加熱昇温することで、容易に起動できる。
したがって、燃料電池を電源とした加熱式薬剤放散装置を環境温度が低い場所でも問題なく使用できる。
また、薬剤保持体4と燃料電池2は離れているので、燃料電池2を外部加熱手段で加熱する際に、その熱が薬剤保持体4に伝わることがなく、薬剤に悪影響を及ぼすことがない。
Therefore, when the environmental temperature is low, the first main body 5 and the second main body 6 are separated, and the fuel cell 2 is heated and heated by an external heating means, so that it can be easily started.
Therefore, the heating type chemical diffusion apparatus using the fuel cell as a power source can be used without any problem even in a place where the environmental temperature is low.
Further, since the medicine holder 4 and the fuel cell 2 are separated from each other, when the fuel cell 2 is heated by the external heating means, the heat is not transmitted to the medicine holder 4 and does not adversely affect the medicine. .

前記外部加熱手段としては、一般的に家庭で常備されているドライヤーなどの乾燥器具や赤外温風機、エアコン、灯油式、電気式、ガス式等の暖房器具などから発生する熱風を利用する。
例えばドライヤーを使用して燃料電池に向けて熱風を当てて加熱する。
または暖房器具からの熱風流路に装置本体を置いて燃料電池を温める。
または使い捨てカイロや再生カイロなどの温熱剤の発熱温度を利用する。例えば、カイロを燃料電池の露出面側に被せたり、燃料電池の収納室内に入れて温める。
前記使い捨てカイロは金属の酸化反応を利用したもので、鉄粉等の金属粉末、反応助剤としての塩類、水、触媒的な働きをする活性炭、及びパーミキュライト、珪藻土、木粉等の保水剤などを透気性の袋に収納して用いる。
または水に溶解する時の水和熱又は溶解熱を利用したもので、水と発熱反応する発熱剤(塩化カルシウム、炭酸ナトリウム、等)と、水又は水を加えて含水させゲル化した吸水性樹脂とを予め分離して収容しておき、必要時にこれらを混合して用いる。
繰り返して使える再生カイロは、ポリエチレングリコール、ポリビニルアルコール、ポリアクリル酸ナトリウム、カルボキシメチルセルロース、カルボキシメチルセルロース多価金属塩等の増粘剤又はゲル化剤からなる高粘度流動体を袋に充填したもので、必要時電子レンジなどで温めて用いる。
上記外として、ノルマルパラフィン、高級アルコール等の有機系蓄熱材と酢酸ナトリウムや塩化マグネシウム等多水塩の無機系蓄熱材を有する水性分散液、熱水、電気カーペットなどの熱を利用することもできる。
As the external heating means, hot air generated from a drying device such as a dryer, an infrared hot air heater, an air conditioner, a kerosene type, an electric type, a gas type heating device or the like generally used at home is used.
For example, a dryer is used to heat the fuel cell with hot air.
Alternatively, the device body is placed in a hot air flow path from the heater to warm the fuel cell.
Alternatively, the heat generation temperature of a thermal agent such as a disposable warmer or a regenerative warmer is used. For example, a warmer is put on the exposed surface side of the fuel cell, or placed in the fuel cell storage chamber to warm it.
The disposable body warmer uses a metal oxidation reaction, such as metal powder such as iron powder, salts as reaction aids, water, activated carbon that acts as a catalyst, and water retention agents such as permiculite, diatomaceous earth, and wood powder. Is stored in an air-permeable bag.
Or it uses heat of hydration or heat of dissolution when it dissolves in water, exothermic agent (calcium chloride, sodium carbonate, etc.) that reacts exothermically with water, and water or water added to contain water and gel The resin is separated and stored in advance, and these are mixed and used when necessary.
Recycled warmer that can be used repeatedly is a bag filled with a high viscosity fluid consisting of a thickener or gelling agent such as polyethylene glycol, polyvinyl alcohol, sodium polyacrylate, carboxymethylcellulose, carboxymethylcellulose polyvalent metal salt, Use with a microwave oven when necessary.
In addition to the above, it is also possible to use heat from aqueous dispersions, hot water, electric carpets and the like, which have organic heat storage materials such as normal paraffin and higher alcohol and polyhydrate inorganic heat storage materials such as sodium acetate and magnesium chloride. .

次に、前述の各部材の具体形状を説明する。
前記第1本体5は周面板5aと上面板5bで下面が開口した箱形状で、上面板5bに開口部10が形成してある。
この開口部10の周縁下部が発熱体取付部11で、周縁上部が薬剤保持体取付部12である。
前記第2本体6は第1本体5が嵌合して着脱自在に取付けられる第1本体取付用開口部13と、この第1本体取付用開口部13に開口した電池本体収納室14と燃料タンク収納室15を有する。
前記電池本体収納室14には燃料電池2の電池本体20が収納して設けてあり、図2に示すように、第1本体5を取り外して離すことで電池本体20が第1本体取付用開口部13から外部に露出する。
前記燃料タンク収納室15に燃料電池2の燃料タンク21が収納してある。例えば、蓋16を外して燃料タンク収納室15を開放し、燃料タンク21を挿入、抜き出しする。
Next, specific shapes of the above-described members will be described.
The first main body 5 has a box shape with a lower surface opened by a peripheral surface plate 5a and an upper surface plate 5b, and an opening 10 is formed in the upper surface plate 5b.
The lower peripheral portion of the opening 10 is a heating element mounting portion 11, and the upper peripheral portion is a medicine holder mounting portion 12.
The second main body 6 includes a first main body mounting opening 13 to which the first main body 5 is fitted and detachably mounted, a battery main body storage chamber 14 opened in the first main body mounting opening 13 and a fuel tank. A storage chamber 15 is provided.
A battery body 20 of the fuel cell 2 is housed and provided in the battery body housing chamber 14, and as shown in FIG. 2, the battery body 20 is opened by removing the first body 5 and separating it. The part 13 is exposed to the outside.
A fuel tank 21 of the fuel cell 2 is stored in the fuel tank storage chamber 15. For example, the lid 16 is removed, the fuel tank storage chamber 15 is opened, and the fuel tank 21 is inserted and extracted.

前記電池本体20は、図3に示すように容器22内に負極(燃料極)23と正極(空気極)24とが電解質層25を介して対向して形成されている。
この負極23は燃料を酸化して燃料から電子とプロトンとを取り出すもので、触媒層とガス透過層とが積層された構造を有している。この負極23の端部には負極端子(図示せず)が配設されている。
前記正極24は酸素を還元して発生させた電子と負極において発生したプロトンとを反応させて水を生成するものである。例えば、負極23と同様の構造を有している。
なお、正極24の端部には正極端子(図示せず)が配設してある。
前記電解質層25は、負極23において発生したプロトンを正極24に輸送するためのものであり、電子伝導性をもたず、プロトンを輸送することが可能な材料により構成されている。
As shown in FIG. 3, the battery body 20 includes a container 22 in which a negative electrode (fuel electrode) 23 and a positive electrode (air electrode) 24 face each other with an electrolyte layer 25 interposed therebetween.
The negative electrode 23 oxidizes the fuel and extracts electrons and protons from the fuel, and has a structure in which a catalyst layer and a gas permeable layer are laminated. A negative electrode terminal (not shown) is disposed at the end of the negative electrode 23.
The positive electrode 24 generates water by reacting electrons generated by reducing oxygen with protons generated in the negative electrode. For example, it has the same structure as the negative electrode 23.
A positive terminal (not shown) is disposed at the end of the positive electrode 24.
The electrolyte layer 25 is for transporting protons generated in the negative electrode 23 to the positive electrode 24, and is made of a material that has no electronic conductivity and can transport protons.

上述の反応過程において、負極23と正極24の間に電位差が生じ発電する。
前記負極23の電解質層25と反対側には、例えば負極22に隣接して燃料保持空間26が設けられている。この燃料保持空間26には、隣接して配設された燃料タンク21の供給パイプ27に対応して前述の燃料供給口28が形成されている。これにより、燃料保持空間26と燃料タンク21内とは供給パイプ27、燃料供給口28を介して互いに連通され、燃料タンク21内の燃料が燃料保持空間26に充填されるようになっている。そして負極23に燃料が供給する。
In the above reaction process, a potential difference is generated between the negative electrode 23 and the positive electrode 24 to generate power.
On the opposite side of the negative electrode 23 from the electrolyte layer 25, for example, a fuel holding space 26 is provided adjacent to the negative electrode 22. In the fuel holding space 26, the above-described fuel supply port 28 is formed corresponding to the supply pipe 27 of the fuel tank 21 disposed adjacent thereto. Thereby, the fuel holding space 26 and the fuel tank 21 are communicated with each other via the supply pipe 27 and the fuel supply port 28, and the fuel in the fuel tank 21 is filled in the fuel holding space 26. Then, fuel is supplied to the negative electrode 23.

前記発熱体3は開口部10よりも大きな板状で、その開口部10周縁下面(発熱体取付部11)に固着して取付けられ、この発熱体3で開口部10を閉塞している。
前記発熱体3の一例を具体的に説明すると、平板状の放熱板が接合した絶縁ケース内に、PTCサーミスタよりなる発熱素子が収容され、蓋で封止されている。このPTCサーミスタ(正特性サーミスタ)は、ある一定温度に達すると電流が減少し、温度が下がると自動的に電流が増加して定温の発熱体として機能するもので温度安定性や安全性が高い。
The heating element 3 has a plate shape larger than the opening 10 and is fixedly attached to the lower surface of the periphery of the opening 10 (the heating element mounting part 11). The heating element 3 closes the opening 10.
An example of the heating element 3 will be described in detail. A heating element made of a PTC thermistor is housed in an insulating case joined with a flat plate-like heat sink and sealed with a lid. This PTC thermistor (positive temperature coefficient thermistor) reduces the current when it reaches a certain temperature, and automatically increases when the temperature drops to function as a constant temperature heating element, and has high temperature stability and safety. .

前記薬剤保持体4は、通気性を有するシートに薬剤を含浸したシート状の薬剤含浸体40と、この薬剤含浸体40を保持する保持容器41を備えている。
前記保持容器41は容器本体42と押えリング43を有し、その容器本体42に薬剤含浸体40を載置し、その容器本体42に押えリング43を嵌合して取付けて薬剤含浸体40を押しつけ保持している。
The drug holding body 4 includes a sheet-shaped drug impregnated body 40 in which a breathable sheet is impregnated with a drug, and a holding container 41 for holding the drug impregnated body 40.
The holding container 41 includes a container main body 42 and a presser ring 43. The drug impregnated body 40 is placed on the container main body 42, and the presser ring 43 is fitted and attached to the container main body 42. Press and hold.

前記第1本体5と第2本体6を図4に示すようにヒンジ17で開閉自在に連結しても良い。
この場合には、第1本体5を第2本体6に対して矢印a方向に回動することで仮想線で示すように、第1本体5と第2本体6が分離して第2本体6の上面が開口して燃料電池2(つまり、電池本体20)が外部に露出する。
The first main body 5 and the second main body 6 may be connected to each other by a hinge 17 so as to be opened and closed as shown in FIG.
In this case, the first main body 5 and the second main body 6 are separated by rotating the first main body 5 with respect to the second main body 6 in the direction of the arrow a, as indicated by phantom lines. The fuel cell 2 (that is, the battery body 20) is exposed to the outside.

次に、本発明の薬剤放散装置の第2の参考例として送風式の薬剤放散装置について説明する。
図5に示すように、装置本体1の第1本体5の開口部10の下方に送風機収納室18を形成し、この送風機収納室18内に送風機19を設ける。
この送風機19はモータ19aでファン19bを回転するもので、第1本体5の開口部10から空気を吸い込んで、吐出口5cから吐出する。
Next, a blowing type drug diffusion device will be described as a second reference example of the drug diffusion device of the present invention.
As shown in FIG. 5, a blower storage chamber 18 is formed below the opening 10 of the first main body 5 of the apparatus main body 1, and a blower 19 is provided in the blower storage chamber 18.
This blower 19 rotates a fan 19b with a motor 19a, sucks air from the opening 10 of the first main body 5, and discharges it from the discharge port 5c.

このようであるから、送風機19を駆動することで薬剤保持体4に空気が流通し、保持している薬剤を大気に放散する。
つまり、この参考例は発熱体3の代りに送風機19を設けたことが前述の参考例と異なり、他の構成は同一である。
Since it is like this, air distribute | circulates to the chemical | medical agent holding body 4 by driving the air blower 19, and the chemical | medical agent currently hold | maintained is dissipated to air | atmosphere.
That is, this reference example is different from the above-described reference example in that a blower 19 is provided instead of the heating element 3, and other configurations are the same.

この参考例においても、図6に示すように第1本体5と第2本体6をヒンジ17で開閉自在に連結しても良い。   Also in this reference example, as shown in FIG. 6, the first main body 5 and the second main body 6 may be connected by a hinge 17 so as to be freely opened and closed.

前述の第1・第2の参考例に用いる薬剤保持体4としては、薬剤含浸体40の材質として、紙類(パルプ、リンター、合成紙など)、木製類(おがくずなど)、セラミック、繊維類(化学繊維、ガラス繊維、炭素繊維など)、天然繊維(木綿、羊毛、絹、麻など)、樹脂類(ポリエチレン、ポリプロピレン、レーヨン、ビスコース、高吸油性ポリマーなど)、各繊維からの不織布、天然植物等の乾燥物などが例示される。
前記薬剤含浸体40の形態としてはシート状、網状、ハニカム状、スノコ状、格子状、綿状、粒状、マット状などが例示される。また、通気性のある袋、容器などに収納したものでも良い。形状としては、円形、四角形、多角形などが例示される。
また、発熱体の発熱温度を低温度(例えば100℃以下)で加熱する場合、前記薬剤保持体の中では、通気性の大きい材料、またその成形物であることが望ましい。例えば、薬剤保持体中を熱気流が通過する、不織布、など材質、網状、ハニカム状、など形状が好ましい。また、多数の小孔を形成しても良い。
また、薬剤の含有量を高める、例えば不織布などをひだ形状にする、など手段も可能である。
また、本発明に用いる薬剤保持体4として、薬液としては後述する薬剤を適当な溶剤、例えばノルマルパラフィン、イソパラフィン、ナフテン系炭化水素等の石油系溶剤に溶解した油性薬液、又は水、界面活性剤等を用いて可溶化させた水性薬液などが挙げられる。
As the drug holder 4 used in the first and second reference examples, the material of the drug impregnated body 40 includes paper (pulp, linter, synthetic paper, etc.), wood (sawdust, etc.), ceramic, fibers (Chemical fiber, glass fiber, carbon fiber, etc.), natural fiber (cotton, wool, silk, hemp, etc.), resins (polyethylene, polypropylene, rayon, viscose, highly oil-absorbing polymer, etc.), non-woven fabric from each fiber, Examples thereof include dried products such as natural plants.
Examples of the form of the drug impregnated body 40 include a sheet shape, a net shape, a honeycomb shape, a slat shape, a lattice shape, a cotton shape, a granular shape, and a mat shape. Moreover, what was accommodated in the air permeable bag, a container, etc. may be used. Examples of the shape include a circle, a quadrangle, and a polygon.
In addition, when heating the heating element at a low temperature (for example, 100 ° C. or lower), it is desirable that the medicine holder is a material having a high air permeability or a molded product thereof. For example, a material such as a nonwoven fabric, a net shape, a honeycomb shape or the like in which a hot airflow passes through the drug holding body is preferable. Also, a large number of small holes may be formed.
In addition, a means for increasing the content of the drug, for example, making a nonwoven fabric into a pleated shape is also possible.
Moreover, as the chemical | medical agent holding body 4 used for this invention, the chemical | medical agent mentioned later as a chemical | medical solution is an oil-based chemical | medical solution which melt | dissolved the chemical | medical agent mentioned later in petroleum solvents, such as normal paraffin, an isoparaffin, a naphthenic hydrocarbon, or water, surfactant. An aqueous chemical solution solubilized using the above or the like.

次に、本発明の薬剤放散装置の第3の参考例として超音波式の薬剤放散装置について説明する。
この参考例は、図7に示すように発熱体、送風機の代りに超音波発振機構7を設け、薬剤保持体の代りに薬液容器8を設け、この超音波発振機構7は燃料電池2を電源として超音波を発振し、その超音波で薬液容器8内の薬液(液状の薬剤)を霧化し大気に放散する。
他の構成は、前述の第1・第2の参考例と同様である。
Next, an ultrasonic drug diffusion device will be described as a third reference example of the drug diffusion device of the present invention.
In this reference example, as shown in FIG. 7, an ultrasonic oscillation mechanism 7 is provided in place of a heating element and a blower, and a chemical solution container 8 is provided in place of a drug holding body. The ultrasonic oscillation mechanism 7 supplies power to the fuel cell 2. Then, an ultrasonic wave is oscillated, and the ultrasonic wave atomizes the chemical liquid (liquid chemical) in the chemical liquid container 8 and diffuses it into the atmosphere.
Other configurations are the same as those of the first and second reference examples described above.

前記超音波発振機構7は、振動板70と発振子71、例えばピエゾ発振子を備え、その発振子71が図示しないピエゾ発振回路に接続して燃料電池2を電源として超音波を発振し、その超音波が振動板70に伝わる。
前記薬剤容器8は、容器本体80内に吸液芯81を挿入したもので、その吸液芯81によって前記振動板70に薬剤を供給する。
このようであるから、振動板70に前述の超音波が伝わることで、前述の吸液芯81で振動板70に供給された容器本体80内の薬液を霧化し、大気に噴霧する。つまり、吸液芯81は薬液を振動板70に供給する薬液供給手段で、吸液芯以外のものを利用できる。例えば振動板に薬液を滴下するなど。
The ultrasonic oscillation mechanism 7 includes a diaphragm 70 and an oscillator 71, for example, a piezoelectric oscillator, and the oscillator 71 is connected to a piezoelectric oscillation circuit (not shown) to oscillate ultrasonic waves using the fuel cell 2 as a power source. Ultrasonic waves are transmitted to the diaphragm 70.
The drug container 8 has a liquid absorption core 81 inserted into the container body 80, and supplies the drug to the diaphragm 70 through the liquid absorption core 81.
Since it is like this, the above-mentioned ultrasonic wave is transmitted to the vibration plate 70, and the chemical liquid in the container body 80 supplied to the vibration plate 70 is atomized by the above-described liquid absorption core 81 and sprayed to the atmosphere. That is, the liquid absorption core 81 is a chemical liquid supply means for supplying a chemical liquid to the vibration plate 70, and a liquid absorption core other than the liquid absorption core can be used. For example, dropping chemicals on the diaphragm.

前記第1本体5内には薬液容器収納室82と超音波発振機構収納室72が形成してあり、この超音波発振機収納室72は噴霧口73で大気に開口している。
前記薬液容器収納室82は連通孔83で電池本体収納室14を連通し、この薬液容器収納室82は上面に形成した排出孔84で大気に開口している。
A chemical container storage chamber 82 and an ultrasonic oscillation mechanism storage chamber 72 are formed in the first main body 5, and the ultrasonic oscillator storage chamber 72 is opened to the atmosphere through a spray port 73.
The chemical liquid container storage chamber 82 communicates with the battery main body storage chamber 14 through a communication hole 83, and the chemical liquid container storage chamber 82 opens to the atmosphere through a discharge hole 84 formed on the upper surface.

前述の参考例でも、図8に示すように、第1本体5と第2本体6をヒンジ17で開閉自在に連結し、起動時には第1本体5を回動して第2本体6の上面を開口して燃料電池2(燃料本体20)を外部に露出するようにすることができる。   Also in the above-described reference example, as shown in FIG. 8, the first main body 5 and the second main body 6 are connected to each other by a hinge 17 so as to be freely opened and closed. The fuel cell 2 (fuel body 20) can be exposed to the outside by opening.

図7に示す超音波式の薬剤放散装置によれば、燃料電池2が発電の際に発生する熱で霧化する薬液を加熱して薬液の粘度を低下することができる。
つまり、燃料電池2からの発生熱は連通孔83から薬液容器8に伝達することで霧化する薬液を加熱して、その粘度を下げ、絶えず、均一な粒子径分布で噴霧できる粘度範囲を維持することができるようにした。また、前述の発生熱は吸液芯81の目詰まり阻止などにも有効利用でき、超音波発振機構7に安定した送液が可能となる。
According to the ultrasonic-type medicine diffusion device shown in FIG. 7, the chemical liquid atomized by the heat generated when the fuel cell 2 generates power can be heated to reduce the viscosity of the chemical liquid.
That is, the generated heat from the fuel cell 2 is transmitted from the communication hole 83 to the chemical liquid container 8 to heat the chemical liquid to be atomized, thereby reducing its viscosity and maintaining a viscosity range that can be sprayed constantly with a uniform particle size distribution. To be able to. Further, the generated heat can be effectively used for preventing clogging of the liquid absorbent core 81 and the liquid can be stably fed to the ultrasonic oscillation mechanism 7.

前述のように超音波を利用して薬液を霧化して噴霧する装置は前述のピエゾ式噴霧装置に限ることはなく、次のような装置でも良い。
第1には、超音波で振動する振動板を薬液中に配設して薬液を霧化する装置、具体的には薬液、薬液を収容した霧化槽、該霧化槽に配設された振動板から構成され、霧化槽に設けられた振動板は、両面に形成された電極部に所定周波数の電圧が印可されることにより、磁歪振動を起こして超音波振動を出力し、薬液に超音波振動を与えられ霧化する。
第2には、超音波で振動する振動板を噴霧筒に配設して噴霧筒内に薬液を吸い上げ霧化する装置、具体的には超音波ポンプ、超音波トランスデューサーを利用するタイプは、圧電素子、液吸上げ口、噴霧筒の機構からなり、圧電素子に交番電圧を負荷させ、圧電素子の固有振動数とトランスデューサーを共振させ、パワーをトランスデューサー先端に拡大し伝達させ、超音波霧化させるものである。
しかし、装置の小型化や取り扱いの簡便性を考慮するとピエゾ式噴霧装置や超音波ポンプ式噴霧装置が好ましい。
As described above, an apparatus for atomizing and spraying a chemical using ultrasonic waves is not limited to the above-described piezo-type spray apparatus, and the following apparatus may be used.
First, a vibration plate that vibrates with ultrasonic waves is disposed in the chemical liquid to atomize the chemical liquid, specifically, the chemical liquid, the atomization tank containing the chemical liquid, and the atomization tank. The diaphragm, which is composed of a diaphragm and is provided in the atomization tank, generates magnetostrictive vibration and outputs ultrasonic vibration by applying a voltage of a predetermined frequency to the electrode portions formed on both sides, to the chemical solution. Atomized with ultrasonic vibration.
Secondly, a device that uses a vibration plate that is vibrated by ultrasonic waves in the spray cylinder and sucks and atomizes the chemical in the spray cylinder, specifically, an ultrasonic pump, a type that uses an ultrasonic transducer, It consists of a piezoelectric element, a liquid suction port, and a spray cylinder mechanism. An alternating voltage is applied to the piezoelectric element, the natural frequency of the piezoelectric element and the transducer are resonated, and the power is expanded and transmitted to the tip of the transducer. Atomized.
However, in consideration of the miniaturization of the apparatus and the ease of handling, a piezo-type spray apparatus and an ultrasonic pump-type spray apparatus are preferable.

前述ようにして噴霧する薬液の噴霧パターンについて述べると、噴霧を連続的に行っても良いし、噴霧を間欠的に行っても良い。間欠噴霧を行う場合は、噴霧粒子が長時間浮遊する粒子径において有効であり、消費電力の低減化を図ることが可能である。また、殺虫剤など使う害虫防除において安全性を高めることもできる。   As for the spray pattern of the chemical liquid to be sprayed as described above, spraying may be performed continuously or spraying may be performed intermittently. When intermittent spraying is performed, it is effective for a particle diameter in which spray particles float for a long time, and it is possible to reduce power consumption. In addition, safety can be improved in controlling pests such as insecticides.

前述の各参考例における発熱体3と薬剤保持体4、送風機19と薬剤保持体4、超音波発信機構7と薬剤容器8が、燃料電池2を電源として薬剤を大気に放散する手段である。   The heating element 3 and the drug holding body 4, the blower 19, the drug holding body 4, the ultrasonic transmission mechanism 7 and the drug container 8 in each of the reference examples described above are means for diffusing the drug to the atmosphere using the fuel cell 2 as a power source.

次に、本発明の実施の形態を説明する。
前述の参考例では、装置本体1を第1本体5と第2本体6を接離自在とし、第1本体5に薬剤を大気に放散する手段を設けると共に、第2本体6に燃料電池2を設けたが、本発明は、装置本体1に薬剤を大気に放散する手段と燃料電池2を平面方向に離隔してそれぞれ設け、その燃料電池2が装置本体1の上面又は下面、又は側面に露出するようにした。
Next, an embodiment of the present invention will be described.
In the above-described reference example, the apparatus main body 1 can be brought into contact with and separated from the first main body 5 and the second main body 6, the first main body 5 is provided with means for releasing the chemical into the atmosphere, and the fuel cell 2 is mounted on the second main body 6. In the present invention, the device main body 1 is provided with means for diffusing the drug into the atmosphere and the fuel cell 2 separately in the plane direction, and the fuel cell 2 is exposed on the upper surface, the lower surface, or the side surface of the device main body 1. I tried to do it.

例えば、図9と図10に示すように、装置本体1に燃料電池取付部90と薬剤放散手段取付部91を、平面方向に離隔して形成し、その燃料電池取付部90に燃料電池2を取付け、その燃料電池2が装置本体1の上面に露出するようにする。
前記薬剤放散手段取付部91に薬剤放散手段、例えば送風機19と薬剤保持体4を取付ける。
For example, as shown in FIG. 9 and FIG. 10, a fuel cell mounting portion 90 and a drug diffusing means mounting portion 91 are formed in the apparatus main body 1 so as to be spaced apart in the plane direction, and the fuel cell 2 is mounted on the fuel cell mounting portion 90. The fuel cell 2 is attached so that the upper surface of the apparatus body 1 is exposed.
The medicine diffusing means, for example, the blower 19 and the medicine holder 4 are attached to the medicine diffusing means mounting portion 91.

このようにすれば、燃料電池2と薬剤(薬剤保持体4)が平面方向に離隔しているので、環境温度が低い場所で使用する際に、外部加熱手段で燃料電池2を加熱昇温した場合に、薬剤に外部加熱手段の熱が伝わり難く、その薬剤に悪影響を及ぼすことがない。   In this way, since the fuel cell 2 and the drug (drug holder 4) are separated in the plane direction, the temperature of the fuel cell 2 is increased by the external heating means when used in a place where the environmental temperature is low. In this case, the heat of the external heating means is not easily transmitted to the medicine, and the medicine is not adversely affected.

次に具体構造を説明する。
前記燃料電池取付部90は、装置本体1の上面に開口した電池本体収納室14と燃料タンク収納室15で構成されている。なお、電池本体20のみを外部加熱手段で加熱昇温するのであれば、電池本体収納室14と薬剤放散手段取付部91との間に燃料タンク収納室15を設けることが好ましい。
前記薬剤放散手段取付部91は、開口部10の周縁上部の薬剤保持体取付部12と、開口部10と連通した送風収納室18で構成されている。
Next, a specific structure will be described.
The fuel cell mounting portion 90 includes a battery main body storage chamber 14 and a fuel tank storage chamber 15 that are open on the upper surface of the apparatus main body 1. If only the battery main body 20 is heated and heated by the external heating means, it is preferable to provide the fuel tank storage chamber 15 between the battery main body storage chamber 14 and the drug diffusion means attachment portion 91.
The medicine diffusing means attaching portion 91 includes a medicine holder attaching portion 12 at the upper peripheral edge of the opening 10 and a blower storage chamber 18 that communicates with the opening 10.

前述のように、電池本体収納室14と燃料タンク収納室15を上面が開放した形状とすれば、外部加熱手段で加熱昇温することが容易であるが、ゴミ等の異物の侵入や外観の見栄え等で問題がある場合には、蓋体を取付けることができる。
例えば、図11に示すように蓋体92を着脱自在に取付け、通常使用時には蓋体92を取付けて各収納室14,15を閉塞してゴミ等の異物が侵入しないようにすると共に、外観の見栄えを良くする。
また、起動時には蓋体92を取り外して各収納室14,15を開放し、電池本体20、燃料タンク21を外部に露出させる。
As described above, if the battery main body storage chamber 14 and the fuel tank storage chamber 15 are open, it is easy to raise the temperature by external heating means. When there is a problem with appearance or the like, a lid can be attached.
For example, as shown in FIG. 11, a lid 92 is detachably attached, and during normal use, the lid 92 is attached to block the storage chambers 14 and 15 so that foreign substances such as dust do not enter and Make it look good.
Further, at startup, the lid 92 is removed to open the storage chambers 14 and 15, and the battery body 20 and the fuel tank 21 are exposed to the outside.

前記燃料電池2(電池本体20)は装置本体1の下面に露出するようにしても良い。
例えば、図12に示すように電池本体収納室14と燃料タンク収納室15を装置本体1の下面に開口させて燃料電池2が装置本体1の下面に露出するようにする。
この場合には、底板93を着脱自在に取付けて電池本体20、燃料タンク21を支持することが好ましい。
The fuel cell 2 (battery body 20) may be exposed on the lower surface of the device body 1.
For example, as shown in FIG. 12, the battery main body storage chamber 14 and the fuel tank storage chamber 15 are opened on the lower surface of the apparatus main body 1 so that the fuel cell 2 is exposed on the lower surface of the apparatus main body 1.
In this case, it is preferable to support the battery main body 20 and the fuel tank 21 by detachably attaching the bottom plate 93.

前記燃料電池2(電池本体20)は装置本体1の側面に露出するようにしても良い。
例えば、図13に示すように電池本体収納室14を装置本体1の側面に開口させて燃料電池2が装置本体1の側面に露出するようにする。
The fuel cell 2 (battery body 20) may be exposed on the side surface of the apparatus body 1.
For example, as shown in FIG. 13, the battery body housing chamber 14 is opened on the side surface of the apparatus body 1 so that the fuel cell 2 is exposed on the side surface of the apparatus body 1.

この本発明の実施の形態においても、前述した参考例に示すように、送風機19、薬剤保持体4の替わりに発熱体3と薬剤保持体4、超音波発振機構7と薬剤容器8を設けて薬剤放散手段としても良いことは勿論である。   Also in this embodiment of the present invention, as shown in the above-mentioned reference example, instead of the blower 19 and the medicine holding body 4, the heating element 3 and the medicine holding body 4, the ultrasonic oscillation mechanism 7 and the medicine container 8 are provided. Of course, it may be used as a medicine diffusion means.

本発明において使用される薬剤としては、芳香剤、消臭剤、殺菌剤、殺ダニ剤、害虫あるいは害獣忌避剤、殺虫剤または害虫の成長制御剤、吸血行動阻止剤などで、揮散性のものが用いられる。
そして、上記の薬剤で、殺虫を目的として使用する場合、従来より用いられている各種揮散性殺虫剤を用いることができ、ピレスロイド系殺虫剤、カーバメート系殺虫剤、有機リン系殺虫剤等を挙げることができる。一般に安全性が高いことからピレスロイド系殺虫剤が好適に用いられる。
さらに、微量で効力を発揮する高活性のメトフルトリン、トランスフルトリン、エムペントリン、テラレスリン、プロフルトリンが薬剤含浸体を薄く、また小さくできることからより好ましい。
また、上記薬剤に薬剤を徐放化する揮散調整剤(ワセリン類、グリコール類など)、酸化防止剤(BHT,BHAなど)、共力剤(ピペロニルブトキサイド、サイネピリン222など)、溶解剤(パラフィン類、多価アルコール類、脂肪酸エステル類など)、紫外線吸収剤、香料などを必要に応じて添加することは勿論である。
Agents used in the present invention include fragrances, deodorants, fungicides, acaricides, pest or pest repellents, insecticides or pest growth regulators, blood-sucking behavior inhibitors, etc. Things are used.
And when using the above-mentioned chemicals for insecticidal purposes, various conventionally used volatile insecticides can be used, including pyrethroid insecticides, carbamate insecticides, organophosphorus insecticides, etc. be able to. In general, pyrethroid insecticides are preferably used because of their high safety.
Furthermore, highly active metofluthrin, transfluthrin, empentrin, teraleslin, and profluthrin that are effective in a small amount are more preferable because the drug-impregnated body can be made thin and small.
In addition, volatilization regulators (such as petrolatums and glycols), antioxidants (such as BHT and BHA), synergists (such as piperonyl butoxide and sinepirin 222), and solubilizers that gradually release the above-mentioned drugs. Of course, paraffins, polyhydric alcohols, fatty acid esters, etc., ultraviolet absorbers, fragrances and the like are added as necessary.

本発明に用いる燃料電池としては、その電解質の種類に基づいて類別されるリン酸型、固体高分子型、溶融炭酸塩型、固定酸化物型、アルカリ型などが挙げられる。薬剤の送風拡散用途の電源としては、室温付近に近い温度で作動可能であること、小型に構成可能であること、などから前述の固体高分子型、アルカリ型の燃料電池が好ましい。
燃料としては、純水素(水素吸蔵合金、水素ボンベ、水素吸蔵カーボンナノチューブなど)液体燃料、天然ガス、ナフサ、石灰ガスなどが挙げられる。使用時の取り扱いが容易であること、簡単な構造で小型であることなどから、前述の純水素や液体燃料が好ましい。また液体燃料は目視できる利点があり、高濃度メタノール、希釈メタノール水溶液、その他エタノール、プロパノール、ジメチルエーテル、エチレングリコ−ルなどが例示されるが、燃料として供給された水素が水素イオンと電子に分解できるものであれば特に限定されない。
また、電池本体としては、前述に説明したセパレータ/負極/電解質/正極/セパレータの単一セルを、任意の目的に合わせてセルを複数枚重ねた構造からなる電池本体を使用することは勿論である。
Examples of the fuel cell used in the present invention include a phosphoric acid type, a solid polymer type, a molten carbonate type, a fixed oxide type, and an alkaline type that are classified based on the type of electrolyte. As the power source for the blast diffusion of the medicine, the above-described solid polymer type and alkaline type fuel cells are preferable because they can operate at a temperature close to room temperature and can be made compact.
Examples of the fuel include pure hydrogen (hydrogen storage alloy, hydrogen cylinder, hydrogen storage carbon nanotube, etc.) liquid fuel, natural gas, naphtha, lime gas, and the like. The above-described pure hydrogen and liquid fuel are preferable because they are easy to handle at the time of use, and have a simple structure and a small size. Liquid fuels have the advantage of being visible, and examples include high-concentration methanol, dilute methanol aqueous solution, ethanol, propanol, dimethyl ether, ethylene glycol, etc., but hydrogen supplied as fuel can be decomposed into hydrogen ions and electrons. If it is a thing, it will not specifically limit.
In addition, as a battery body, it is a matter of course that a battery body having a structure in which a plurality of cells are stacked in accordance with an arbitrary purpose is used as the separator / negative electrode / electrolyte / positive electrode / separator described above. is there.

1…装置本体、2…燃料電池、3…発熱体、4…薬剤保持体、5…第1本体、6…第2本体、7…超音波発振機構、8…薬液容器、14…電池本体収納室、15…燃料タンク収納室、19…送風機、20…電池本体、21…燃料タンク、90…燃料電池取付部、91…薬剤放散手段取付部、91,92…蓋体。   DESCRIPTION OF SYMBOLS 1 ... Apparatus main body, 2 ... Fuel cell, 3 ... Heat generating body, 4 ... Drug holding body, 5 ... 1st main body, 6 ... 2nd main body, 7 ... Ultrasonic oscillation mechanism, 8 ... Chemical solution container, 14 ... Battery main body accommodation Chamber 15, Fuel tank storage chamber 19, Blower 20, Battery body 21, Fuel tank 90, Fuel cell mounting portion 91, Drug diffusion means mounting portion 91, 92 Lid

Claims (5)

装置本体1に、燃料電池取付部90と薬剤放散手段取付部91を平面方向に離隔して形成し、
前記燃料電池取付部90に燃料電池2を、装置本体1の上面又は下面又は側面に露出するように取付け、
前記薬剤放散手段取付部91に、前記燃料電池2を電源として薬剤を大気に放散する薬剤放散手段を取付けたことを特徴とする薬剤放散装置。
The apparatus main body 1 is formed with a fuel cell attachment portion 90 and a drug diffusion means attachment portion 91 spaced apart in the plane direction,
The fuel cell 2 is attached to the fuel cell attachment portion 90 so as to be exposed on the upper surface, the lower surface or the side surface of the apparatus main body 1,
A drug diffusing device, wherein a drug diffusing means for diffusing a drug into the atmosphere using the fuel cell 2 as a power source is attached to the drug diffusing means mounting portion 91.
前記燃料電池取付部90は、装置本体1の上面に開口した電池本体収納室14と燃料タンク収納室15を有し、その電池本体収納室14に電池本体20を設け、燃料タンク収納室15に燃料タンク21を設けた請求項1記載の薬剤放散装置。   The fuel cell mounting portion 90 has a battery main body storage chamber 14 and a fuel tank storage chamber 15 opened on the upper surface of the apparatus main body 1, and a battery main body 20 is provided in the battery main body storage chamber 14. The drug diffusion device according to claim 1, further comprising a fuel tank. 前記電池本体収納室14、燃料タンク収納室15の上面の開口を閉塞する蓋体92を着脱自在に設けた請求項2記載の薬剤放散装置。   The drug diffusion device according to claim 2, wherein a lid 92 that closes the openings on the upper surfaces of the battery main body storage chamber 14 and the fuel tank storage chamber 15 is detachably provided. 前記電池本体収納室14と薬剤放散手段取付部91との間に燃料タンク収納室15を設けた請求項2又は3記載の薬剤放散装置。   The drug diffusion device according to claim 2 or 3, wherein a fuel tank storage chamber (15) is provided between the battery main body storage chamber (14) and the drug diffusion means mounting portion (91). 燃料電池2を電源とする発熱体3と、この発熱体3で加熱されて薬剤を蒸散する薬剤保持体4、又は燃料電池2を電源とする送風機19と、この送風機19による空気が流通することで薬剤を放散する薬剤保持体4、又は燃料電池2を電源とする超音波発振機構7で発振した振動で薬液容器8内の薬液を大気に噴霧することで薬剤放散手段とした請求項1,2,3,4いずれか1項に記載の薬剤放散装置。   A heating element 3 that uses the fuel cell 2 as a power source, a medicine holder 4 that is heated by the heating element 3 to evaporate the medicine, or a blower 19 that uses the fuel cell 2 as a power source, and air from the blower 19 circulates. The medicine holding means 4 for diffusing the medicine or the ultrasonic oscillation mechanism 7 using the fuel cell 2 as a power source for spraying the chemical liquid in the chemical liquid container 8 to the atmosphere by vibration oscillated by the ultrasonic wave oscillation mechanism 7. The drug diffusion device according to any one of 2, 3, and 4.
JP2011031529A 2011-02-17 2011-02-17 Drug diffusion device Active JP4901999B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011031529A JP4901999B2 (en) 2011-02-17 2011-02-17 Drug diffusion device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011031529A JP4901999B2 (en) 2011-02-17 2011-02-17 Drug diffusion device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005097711A Division JP4790294B2 (en) 2005-03-30 2005-03-30 Drug diffusion device

Publications (2)

Publication Number Publication Date
JP2011092217A true JP2011092217A (en) 2011-05-12
JP4901999B2 JP4901999B2 (en) 2012-03-21

Family

ID=44109879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011031529A Active JP4901999B2 (en) 2011-02-17 2011-02-17 Drug diffusion device

Country Status (1)

Country Link
JP (1) JP4901999B2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6131074A (en) * 1984-07-24 1986-02-13 日本たばこ産業株式会社 Smoking composition
JPH02123879A (en) * 1988-11-01 1990-05-11 Canon Inc Replacement lens unit and image pickup device
JP2005000111A (en) * 2003-06-13 2005-01-06 Seiko Instruments Inc Agent-spraying apparatus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6131074A (en) * 1984-07-24 1986-02-13 日本たばこ産業株式会社 Smoking composition
JPH02123879A (en) * 1988-11-01 1990-05-11 Canon Inc Replacement lens unit and image pickup device
JP2005000111A (en) * 2003-06-13 2005-01-06 Seiko Instruments Inc Agent-spraying apparatus

Also Published As

Publication number Publication date
JP4901999B2 (en) 2012-03-21

Similar Documents

Publication Publication Date Title
JP4790294B2 (en) Drug diffusion device
JP5152618B2 (en) Blower type drug diffusion device using fuel cell as power source
US9278365B2 (en) Volatile material dispenser and method of emitting a volatile material
US6548015B1 (en) Self-simmering fragrance dispenser
US20050089502A1 (en) Effervescent delivery system
JP3930632B2 (en) Piezo-type chemical spraying device
JP4790293B2 (en) Drug diffusion device
JP4901999B2 (en) Drug diffusion device
JP2759446B2 (en) Transpiration device and method
CN100579369C (en) Fan-assisted medicine diffuser employing fuel cell as power supply
JP2005218305A (en) Chemical evaporator
JP2006121988A (en) Method for controlling insect pest
US20230320339A1 (en) Flameless energizer for treatment agent
JP2013116057A (en) Thermal evaporation device
JP4389212B2 (en) Heated chemical vaporizer
JP5564703B2 (en) Heating transpiration device
JP2002060302A (en) Volatilizable chemical preparation, and mildewproof material for air conditioner by using the same
JP2011057608A (en) Chemical liquid for piezo type sprayer
US20220168457A1 (en) Flameless energized emanator
WO2002038195A1 (en) Efficient self-heating device for dispensing volatile materials
KR200350306Y1 (en) Liquid Dispenser of Using Ultrasonic Actuator
JPS5919534A (en) Continuous supply of volatile substance
JP2004187582A (en) Manual-type heat volatilizer
JP2019041581A (en) Chemical volatilizing container and chemical volatilizing device
JP2002186399A (en) Apparatus for volatilizing chemical

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111221

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111227

R150 Certificate of patent or registration of utility model

Ref document number: 4901999

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150113

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250